Atara Biotherapeutics: Q3 Earnings Snapshot
In this article:
THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Wednesday reported a loss of $69.8 million in its third quarter.
The Thousand Oaks, California-based company said it had a loss of 66 cents per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.
The drug developer posted revenue of $2.1 million in the period.
The company's shares closed at $1.30. A year ago, they were trading at $4.66.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA
